Concetti’s Post

Unlocking the Power of Elderberry: A Deep Dive into Immune-Boosting Excellence 💡 Delve into the extraordinary world of Sambucus nigra, where the Black Elderberry takes center stage with its unparalleled benefits and scientific endorsement. As a prominent species within the Elderberry family, Sambucus nigra boasts a rich heritage, presenting glossy black berries teeming with flavonoids and other health-centric phytochemicals. Scientific studies have unveiled the impressive immune-boosting capabilities of this botanical marvel. Sambucus nigra, abundant in bioactive compounds, particularly anthocyanins, stands as a testament to nature's power to enhance immune function. Its antioxidant and anti-inflammatory effects have sparked widespread interest in the nutraceutical industry. Stay tuned as we unravel the full story of Elderberry's potential, sharing in-depth insights and detailing how this botanical treasure aligns with our commitment to develope excellence in the nutraceutical's industry 🌐  Visit our website 👉🔗https://lnkd.in/dHAWPMTw #ElderberryPower #ImmuneBoosting #SambucusNigra #NutraceuticalInnovation #StayTuned

Benefits of digitalizing healthcare processes: ⚫ Increased patient #safety, ⚫ Reduced #paperwork, ⚫ Reduced #infection risk. #Kudos to Jakub Fejfar and team of Nemocnice AGEL Nový Jičín a.s. for pioneering and showcasing real #digitaltransformation in #healthcare. 👍

Come check us out and see for yourself how we can help you and your practice soar!

Neolytica - A QPharma Company - had a tremendous year of growth and innovation, onboarding 15 out of the top 50 Pharma companies this year alone with a remarkable growth of 150%. Our innovative solution of measuring the impact for medical affairs and marketing through "Sentiment Analysis" has compelled the industry to look beyond generic syndicated companies and use more innovative companies like ours. #Neolytica #QPharma #Innovation #SentimentAnalysis #MedicalAffairs #Marketing

Thanks THEXELE (Thailand) for this great Review of my new single ‘Sonatina in C sharp’! Link to Full Review: https://lnkd.in/eEmpAVH8

Catailyst Regulatory Event Snippets: Drug Approval in a Country Approval in China Shanghai Kechow Pharma, Inc. China National Medical Products Administration Approval of Tunlametinib (HL-085), the first approved targeted therapy NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1 #melanoma a potential best-in-class MEK inhibitor based on positive data from the pivotal Phase 2 study #Tunlametinib is a small molecule inhibitor of Mitogen-activated protein kinase kinase (MEK) 

Our story of regeneration began in Sanremo, in 1952, with the visionary intuition of Arnolfo Mastelli. Then, over the years, innovation became the heart of our business until the development of Polynucleotides HPT®. Read the first part of our story in the pictures. #Mastelli #MastelliAesthetics #Polynucleotides #HighPurificationTechnology #PNHPT®#AtTheOriginOfRegeneration #AestheticMedicine #Regeneration #SkinPriming 

Noroviruses infect host cells by first interacting with specific sugars (or glycans) that are present on the host cells' surface, called histo-blood group antigens (HBGAs). This interaction occurs through the norovirus major capsid protein VP1 and, more specifically, through its protruding domain (P-domain). Therefore, studying the norovirus P-domain is essential to better understand how noroviruses bind to and infect host cells and to design glycan-based drugs that can hinder this interaction. By using P-domains of norovirus strains of interest produced in bacteria, Luca Pisapia [DC5] is currently studying how these domains interact with different human glycans in CNRS (Grenoble, France). To achieve this, Luca is using different biophysical techniques, such as titration calorimetry, surface plasmon resonance, biolayer interferometry, and protein crystallography. In the end, the aim of this project is to unravel the structural aspects of the binding of norovirus strains of interest to different glycans and to help other GlycoNoVi Research Fellows designing glycan-based drugs that could prevent the norovirus-HBGA interaction. Get to know more about his research (and more!) in this video that he made for you. https://lnkd.in/djJtf5ve

The Juvelook Masterclass on 2nd June 2024 was an insightful session where Dr Choi, Dr Stephanie and Dr Edmond led an engaging discussion on the Advanced Hybrid Biostimulator, Juvelook. We express our deepest appreciation to the participating doctors who attended our masterclass. Join us in our upcoming masterclass by contacting our Elogio Sales Representative. Elogio, Your Companion to SkinHealth #Elogio #ElogioAsia #ElogioEducates #ElogioEducatesAPAC

🩺 Discover firsthand insights into pharmacogenomics (PGx) from Charles Gloor, Non-Executive Director at Mantara! 👨⚕️ In this short video, Charles shares his experience working in the field of pharmacogenomics, why he was so delighted to join Mantara, and his personal experience taking Mantara's simple PGx test. Discover more about personalised medicine on our website, or drop us a message if you have any questions! 🧬 #PGx #MantaraHealth #Pharmacogenomics